0000000000255470

AUTHOR

Benjamin Struchen

OP VI – 5 Spatial and temporal variability of personal exposure to radio frequency electromagnetic fields in children in europe

Background/aim Exposure to radiofrequency electromagnetic fields (RF-EMF) has rapidly increased and little is known about exposure levels in children. This study aims to describe personal RF-EMF environmental exposure levels from handheld devices and fixed site transmitters in European children and its day-to-day and year-to-year repeatability. Methods Environmental RF-EMF exposure (µW/m 2 ) was measured in 529 children (ages 8–18) in Denmark, the Netherlands, Slovenia, Switzerland, and Spain using personal portable exposure metres over 3 days in 2014–2016, and repeated in 28 children one year later. Metres captured exposure every 4 s. Activity diaries collected children’s location and use …

research product

Personal exposure to radio-frequency electromagnetic fields in Europe: Is there a generation gap?

Background: Exposure to radiofrequency electromagnetic fields (RF-EMF) from mobile communication technologies is changing rapidly. To characterize sources and associated variability, we studied the differences and correlations in exposure patterns between children aged 8 to 18 and their parents, over the course of the day, by age, by activity pattern, and for different metrics of exposure. Methods: Using portable RF-EMF measurement devices, we collected simultaneous real-time personal measurements of RF-EMF over 24 to 72 h in 294 parent-child pairs from Denmark, the Netherlands, Slovenia, Switzerland, and Spain. The devices measured the power flux density (mW/m(2)) in 16 different frequency…

research product

Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries

BACKGROUND Leukaemias comprise a heterogenous group of haematological malignancies. In CONCORD-3, we analysed data for children (aged 0-14 years) and adults (aged 15-99 years) diagnosed with a haematological malignancy during 2000-14 in 61 countries. Here, we aimed to examine worldwide trends in survival from leukaemia, by age and morphology, in young patients (aged 0-24 years). METHODS We analysed data from 258 population-based cancer registries in 61 countries participating in CONCORD-3 that submitted data on patients diagnosed with leukaemia. We grouped patients by age as children (0-14 years), adolescents (15-19 years), and young adults (20-24 years). We categorised leukaemia subtypes a…

research product